ISSN 1679-4974 printed version
RESS follows the guidance provided in the document entitled “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals”, issued by the International Committee of Medical Journal Editors (ICMJE) – available from http://www.icmje.org/ (English) and from https://goo.gl/HFaUz7 (Portuguese).
RESS has adopted the principles of publication ethics contained in the Code of Conduct of the Committee on Publication Ethics (COPE), available from: https://publicationethics.org/resources/resources-and-further-reading/international-standards-editors-and-authors.
Practices in contravention of scientific integrity, such as plagiarism, self-plagiarism, data fabrication, redundant publication and undisclosed conflicts of interest, among other practices involving misconduct, will be evaluated by members of the Editorial Core Group and the Editorial Committee, who are independent in relation to the editorial process of the manuscript in question, according to the COPE flowcharts (http://publicationethics.org/resources/flowcharts) and other COPE recommendations, which will immediately communicate the authors as to its decision and all the steps of this process. RESS uses the iThenticate system for identifying plagiarism
RESS has a Statement on Publication Ethics which expresses its commitment to ethics by adopting best scientific publication practices.
Ethics in research involving human beings
Observance of ethical precepts in the conduct and publication of research results is the sole responsibility of the authors, and the ethical recommendations contained in the Declaration of Helsinki must be respected. In the case of research with human beings in Brazil, authors must fully comply with the norms contained in the corresponding National Health Council Resolutions. Whenever pertinent, the protocol number and the date of approval by the Research Ethics Committee should be informed. In the case of a clinical trial, the identification number of one of the clinical trial registries validated by the World Health Organization (WHO) and the ICMJE will be required.
Conflicts of interest
Conflicts of interest are situations in which there are interests – apparent or not – capable of influencing the process of manuscript preparation and review. They are conflicts of a diverse nature – personal, commercial, political, academic or financial – to which any person may be subject.
Authors must acknowledge and disclose such interests, when they exist, by means of a Statement of Responsibility, which must be signed by all authors during manuscript submission, and the ICMJE disclosure form. The conflict of interest statement will be published in the manuscript if it is approved.
Ad hoc reviewers involved in the editorial processing must declare, in their manuscript review report, whether they have any conflicts of interest. The main reviewer conflicts of interest are:
Editors and members of the Editorial Committee have submitted a disclosure of conflicts of interest.
As a means of ensuring the editorial independence of the journal from its funding institution, the decision on approval of manuscripts for publication is made by the Editorial Committee and the decision on rejection of manuscripts that are being processed is validated by at least two members of the Editorial Core Group.
Authors must declare that they are responsible for the veracity and uniqueness of their work by signing a Statement of Responsibility.
Authorship criteria must comply with the ICMJE/ Vancouver Style deliberations, which recognize as authorship criteria substantial contributions to the following four activities: (i) study concept or design, or data collection, analysis and interpretation; (ii) drafting or relevant critical review of the intellectual content of the manuscript; (iii) final approval of the version to be published; and (iv) responsibility for all aspects of the work, including ensuring its accuracy and completeness. All those designated as authors must meet the four authorship criteria.
Right to reproduce
Content published by RESS is licensed under the Creative Commons Attribution-type license (CC-BY), under which others are allowed to distribute, remix, adapt and build upon published work, even for commercial purposes, as long as due authorship credit is given.
Open science and data sharing
RESS is aligned with the principles of open science. Manuscripts previously published on non-commercial preprint servers are welcomed, such as SciELO Preprints, bioRxiv and medRxiv, provided they have not been simultaneously submitted to another journal for peer review. The submitting author should inform RESS regarding preprint deposition by completing the Open Science Conformity Form, which should be submitted as a supplementary file together with the manuscript.
RESS currently adopts the double-blind peer review model. In line with the progressive transparency of the manuscript review process, the name of the associate editor involved in the editorial process is included in the published manuscript.
Access to the study databases may be requested at any stage of the editorial process. RESS encourages deposition and sharing of research data supporting the publication of the manuscript in public data repositories, such as the SciELO Data repository. For detailed instructions on data deposition, click here.
RESS also encourages deposition and sharing of statistical software programming routines used in data analysis, in the form of supplementary materials.
Sex and gender equity
Manuscripts submitted to RESS should observe the principles of the Sex and Gender Equity in Research (Sex and Gender Equity in Research - SAGER) Guidelines. According to these Guidelines, the terms sex (biological attribute) and gender (shaped by social and cultural circumstances) should be used with care, so as to avoid confusion in their use.
Instrucciones a los autores
The RESS Editorial Core Group receives manuscripts in the following modalities:
a) Original article – an original research product falling into one or more of the several thematic areas of surveillance, prevention and control of diseases and health conditions of public health interest.
b) Review article
c) Research note – concise report of final or partial results (preliminary note) of original research.
d) Experience report – description of an experience in the area of epidemiology, surveillance, prevention and control of diseases and health conditions of public health interest; it should be prepared when invited to do so by the editors.
e) Opinion article – succinct commentary on specific themes to promote debate in the field of epidemiology and/or health surveillance, based on scientific evidence and expressing the authors' qualified opinion; it must be written by a specialist, invited by the editors.
f) Debate – theoretical article written by a specialist, invited by the editors, which will receive comments and/or criticisms, through rejoinders, signed by specialists, also invited by the editors.
g) Investigation of events of public health interest – an original product of an experience in the area of epidemiology, surveillance, prevention and control of diseases and health conditions of public health interest.
h) Profile of national health databases – description of Brazilian bases of interest for epidemiology, disease surveillance, prevention and control, by invitation of the editors.
i) Letters – brief comments and/or criticisms, related to an article published in the most recent issue of the journal, which may be published by decision of the editors and accompanied by a reply letter from the authors of the commented article.
The characteristics of the modalities RESS receives are summarized in the box below.
Box: Manuscript modality characteristics.
At the discretion of the editors, other article formats may be published, such as tools for health surveillance management (limit: 3,500 words), epidemiology applications (limit: 3,500 words), interviews with personalities or authorities (limit: 800 words), reviews of contemporary works (limit: 800 words), thematic series articles and editorial notes.
In preparing manuscripts, authors should be guided by the ICMJE Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (English and Portuguese versions).
Manuscript structure should conform to the guidelines provided in the scientific writing guides, according to their design.
Only manuscripts that are in agreement with the Submission Template will be accepted. RESS receives manuscripts written in Portuguese, double-spaced, 12 point Times New Roman font, in RTF (Rich Text Format), DOC or DOCX (Word document) format. Footnotes will not be accepted. Each manuscript must contain:
a) manuscript modality;
Four to six keywords should be selected, with one of them referring to the study design. The keywords must be taken from the list of Health Sciences Descriptors (Descritores em Ciências da Saúde - DeCS) (available from: http://decs.bvs.br) and presented in Portuguese, English and Spanish.
a) Main results: briefly describe the answer to the study objective;
The text of manuscripts in the original article and research note modalities must contain the following sections, in the following order: Introduction, Methods, Results, Discussion, Author Contributions and References. Tables, boxes and figures should be referred to in the “Results” section and presented at the end of the article, when possible, or in a separate file (in editable format). The content of the sections should cover the following aspects:
Avoiding use of uncommon abbreviations or acronyms is recommended. Abbreviations or acronyms should only be used when they are established in the literature, and care should be taken to ensure the clarity of the manuscript. Authors may consult the Ministry of Health “Siglário Eletrônico” or the National Health Foundation “Manual de editoração e produção visual” (Brasil. Fundação Nacional de Saúde. Manual de editoração e produção visual da Fundação Nacional de Saúde. Brasília: Funasa, 2004. 272p.).
Manuscripts are to be submitted to RESS via the SciELO Publication System. Prior to submission, however, authors must prepare the following documents:
1. Statement of Responsibility, signed by all authors, scanned in PDF format;
Manuscript evaluation process
RESS will only receive manuscripts formatted in accordance with these Instructions and the subject matter of which falls within the scope of the journal.
A preliminary review will verify editorial and technical aspects, including but not limited to potential for publication, interest to the journal's readers, and compliance with ethical requirements. Manuscripts that do not meet these requirements will be rejected. Manuscripts considered potentially publishable in RESS, in turn, will undergo the editorial process, which is composed of the steps specified below.
The reviews undertaken at each stage of the editorial process will be sent to the authors, through the submission system, with a defined deadline for reformulation. Authors are advised to pay attention to the communications that will be sent to the e-mail address they informed at submission, as well as to meet the deadlines for replying. Failure to observe the deadlines for replying, especially when not justified, may be grounds for discontinuation of the editorial processing of the manuscript. If the manuscript is approved for publication, but the need for adjustments to the text is still identified, the editors of the journal reserve the right to do so, and the authors will be informed thereof. It is important to emphasize that, in all stages, more than one review round may be necessary.
At the time of submission, authors may indicate up to three possible ad hoc reviewers, experts in the subject of the manuscript, and up to three expert reviewers to whom they would not like their manuscript to be submitted. The editors of the journal will decide whether or not to accept the authors’ suggestions.
Following approval, manuscripts proceed to editorial production, consisting of the following steps:
1) Final editing;
Manuscript processing flowchart (attached).
Authors may contact the RESS Secretariat, via e-mail firstname.lastname@example.org or email@example.com if they have queries about any aspects relating to these Instructions, or if they need information on their manuscript’s progress, so as to avoid time gaps in the editorial process.
Coordenação-Geral de Desenvolvimento da Epidemiologia em Serviço/SVS/MS
Updated version issued in January 2022.
[Home] [About the journal] [Editorial board] [Subscriptions]
All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License attribution-type BY-NC.
Epidemiologia e Serviços de Saúde
Coordenação-Geral de Desenvolvimento da Epidemiologia em Serviços - CGDEP
SRTVN Quadra 701, Via W S Norte, Lote D, Edifícil P0700
+55 61 3315-3464
Fax: +55 61 3315-3464
firstname.lastname@example.org / email@example.com